HDFCL30ETF vs NIPPON INDIA PHARMA FUND

Portfolio Overlap Analysis · HDFC vs Nippon

13.8%
Low Overlap
4 common stocks · Rank #16364 of 28,292 pairs
Fund A
HDFCL30ETF
HDFC · Equity - Other
Fund B
NIPPON INDIA PHARMA FUND
Nippon · Sectoral - Pharma

Common Holdings (4)

StockWt% in HDFCL30ETFWt% in NIPPON INDIA PHARMAOverlap
Apollo Hospitals Enterprise Limited
Healthcare Services
5.17%3.73%3.73%
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
13.08%3.57%3.57%
Dr. Reddy's Laboratories Limited
Pharmaceuticals & Biotechnology
5.81%3.38%3.38%
Cipla Limited
Pharmaceuticals & Biotechnology
5.67%3.08%3.08%

Unique to HDFCL30ETF

  • State Bank of India4.83%
  • ICICI Bank Ltd.4.42%
  • HDFC Bank Ltd.4.01%
  • Hindustan Unilever Ltd.3.91%
  • Nestle India Ltd.3.70%
  • Titan Company Ltd.3.66%
  • Britannia Industries Ltd.3.64%
  • UltraTech Cement Limited3.63%
  • SBI Life Insurance Company Ltd.3.59%

Unique to NIPPON INDIA PHARMA

  • Lupin Limited7.99%
  • Divi's Laboratories Limited6.56%
  • MedPlus Health Services Limited3.70%
  • Max Healthcare Institute Limited3.49%
  • Vijaya Diagnostic Centre Limited3.49%
  • Ajanta Pharma Limited3.41%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
10.0% (3)
Healthcare Services
3.7% (1)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFCL30ETF

More comparisons for NIPPON INDIA PHARMA

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.